Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALL
Clinical trial NCT05557110 · COMPLETED
Trial details
- NCT number
- NCT05557110
- Sponsor
- Chen Suning
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-08
- Primary completion
- 2024-01-05
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.